Chargement en cours...
Lesinurad: what the nephrologist should know
Lesinurad is an oral inhibitor of the monocarboxylic/urate transporter URAT1 encoded by the SLC22A12 gene. Market authorization was granted in February 2016 in Europe and December 2015 in the USA. As a potentially nephrotoxic uricosuric drug acting on the kidney, nephrologists should become familiar...
Enregistré dans:
| Publié dans: | Clin Kidney J |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5622894/ https://ncbi.nlm.nih.gov/pubmed/28979780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfx036 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|